Cell Signaling Technology, Inc.

If you can't trust your antibody, you can't trust your results. The world’s best researchers rely on CST® reagents and cite them more than any others.

Find out why: https://hubs.ly/Q04hVpvf0

Studying genomic instability? 🔬

The new, IHC-validated Rad51 (F4L4Y) Rabbit monoclonal antibody #84555 provides a clear, functional readout of homologous recombination repair (HRR).

• Visualize Foci: Confirm HRR integrity and assess PARP inhibitor sensitivity.

• IHC-Validated: Optimized for FFPE tissue from PDX, organoids, and human, mouse, rat, and monkey models.

See the data and add Rad51 (F4L4Y) Rabbit mAb #84555 to your cart. https://hubs.ly/Q04nTsMf0

High-content imaging (HCI) utilizes automated microscopy to capture intricate cellular details, whereas high-content analysis (HCA) employs advanced algorithms to convert these images into quantitative datasets by measuring parameters such as intensity, texture, and spatial localization.

Together, HCI and HCA facilitate high-content screening (HCS), a powerful methodology for evaluating large-scale libraries containing thousands to millions of compounds.

Whether you’re doing HCI, HCA, or HCS, you’ll find high-performance, application-specific, validated antibodies guaranteed to work in your High Content Anything assays at CST: https://hubs.ly/Q04j943P0

🔬Mapping phenotypic plasticity in your tumor models? Tap an expert‑curated shortlist of markers for EMT, blocked differentiation, and transdifferentiation—all in one place.

🧰 Find key pathway diagrams and antibody tools to build your research toolbox on the .

Unlocking Phenotypic Plasticity | Hallmarks of Cancer Research Learn how mechanisms like dedifferentiation and transdifferentiation contribute to phenotypic plasticity to drive cancer progression and therapy resistance